VANCOUVER, BC / May 31, 2024 / TheNewswire / AREV Life Sciences Global Corp. (CSE: AREV) (OTC: AREVF) (“AREV” or “the Company”) Arev Life Sciences Global Corp (CSE: AREV, US AREVF), a leading innovator in the life sciences, is pleased to announce its strong support for the recent passage of Bill C-368 in the Canadian Parliament. This landmark legislation amends the Food and Drugs Act to ensure that natural health products (NHPs) are not subject to the same stringent regulatory framework as pharmaceutical drugs, preserving their accessibility and affordability for Canadians.

Supporting Combination Therapy and Health Maintenance

Bill C-368 marks a significant victory for the natural health products industry and for consumers who rely on these products for their daily health and wellness needs. By distinguishing NHPs from therapeutic products, the legislation acknowledges the unique role that natural products play in supporting health and well-being.

 

"Natural products are a vital component of combination therapy," stated Michael Withrow, CEO of Arev Life Sciences Global Corp. "They offer synergistic benefits when used alongside conventional treatments, enhancing the efficacy of pharmaceuticals and supporting the maintenance of good health. This bill ensures that Canadians continue to have access to these essential products without the undue burden of over-regulation."

 

Preserving Industry and Consumer Choice

The natural health products industry is a significant contributor to the Canadian economy, employing over 54,000 people and generating substantial economic activity. The passage of Bill C-368 ensures the sustainability of this industry, protecting small businesses and preserving consumer choice.

 

"We applaud the Canadian Parliament for recognizing the importance of natural health products," added Withrow. "The distinction made by Bill C-368 between NHPs and therapeutic drugs is a crucial step in maintaining the accessibility and affordability of these products. This is not just a win for the industry but also for the millions of Canadians who use natural health products daily to enhance their quality of life."

For further information, contact Mike Withrow, arevlifesciences@gmail.com 778-896-6536. For more information visit www.arevlifesciences.com.

On behalf of the Board,

Michael C. Withrow
CEO & Director

About AREV Life Sciences Global Corp.

Arev Life Sciences Global Corp is a biotechnology company dedicated to the discovery and commercialization of innovative solutions for health and wellness. The company's mission is to harness the power of natural compounds to develop effective, sustainable health products that complement conventional therapies and support overall health.

NEITHER THE CANADIAN SECURITIES EXCHANGE NOR ITS REGULATIONS SERVICES PROVIDER HAVE REVIEWED OR ACCEPT RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.

FORWARD LOOKING INFORMATION

Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in policies of the CSE) accepts responsibility for the adequacy or accuracy of this release. This news release may include forward-looking statements that are subject to risks and uncertainties. All statements within, other than statements of historical fact, are to be considered forward looking. Although the Company believes the expectations expressed in such forward looking statements are based on reasonable assumptions, such statements are not guarantees of future performance and actual results or developments may differ materially from those in forward-looking statements. Factors that could cause actual results to differ materially from those in forward-looking statements include market prices, exploitation and exploration successes, and continued availability of capital and financing, and general economic, market or business conditions. There can be no assurances that such statements will prove accurate and, therefore, readers are advised to rely on their own evaluation of such uncertainties. We do not assume any obligation to update any forward-looking statements except as required under the applicable laws. This press release contains forward-looking statements. The use of any of the words "anticipate", "continue", "estimate", "expect", "may", "will", "project", "should", "believe" and similar expressions are intended to identify forward-looking statements.  Although the Company believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because the Company can give no assurance that they will prove to be correct. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. These statements speak only as of the date of this press release. Actual results could differ materially from those currently anticipated due to a number of factors and risks various risk factors discussed in the Company’s Management’s Discussion and Analysis under the Company’s profile on www.sedarplus.ca.